Menu

Tag Archive: APMA

1. MIPS Quality Measure #126-Diabetic Foot Neurological Exam

   November 15, 2018 4:54 pm Leave a Comment

   

    

   CMS has recently updated its MIPS (Merit-based Incentive Payment System) Quality Measures. Measure #126 continues to be retained for performance of neurological exams on the feet of diabetic patients. As Measure Steward for this indicator, APMA (American Podiatric Medical Association) has done an excellent job creating a flowchart on implementation. Consistent with prior years, evaluation includes at least annual testing with the 10 gm monofilament plus one of the following:

   Vibration Test Using 128 Hz Tuning Fork
   Pinprick Sensation
   Ankle Reflexes
   Vibration Perception Threshold

   O’Brien Medical is gratified to see that CMS has included vibration testing in two of its four recommended adjunct tests. This decision also reflects current ADA (American Diabetes Association) recommendations.

    

2. Dr. O’Brien Lectures on Neuropathy at APMA Region One Conference

   October 26, 2017 3:56 pm Leave a Comment

   Company CEO, Todd O’Brien, recently presented a lecture at the APMA Region One Conference in Quincy, MA. His topic was an update on diabetic peripheral neuropathy and its clinical implications for medical professionals. The content of the talk was drawn from his own research and experience as well the latest findings from the medical literature.  Approximately 200 podiatrists from the New England region were in attendance.

   

3. APMA2015 Meeting a Success

   July 27, 2015 9:00 pm Leave a Comment

   The company attended it’s first APMA National Meeting in Orlando last week. The event was an excellent venue for showcasing the ETF to the over 1,000 podiatrists in attendance. The company was delighted to have the opportunity to build new relationships with many of the attendees including several nationally recognized thought leaders.

    

   

   Dr. O’Brien engages in discussion with doctors at the APMA National.